| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4005255 | American Journal of Ophthalmology | 2006 | 7 Pages |
Abstract
Topical IFN-α2b is an important treatment modality for recalcitrant OSSN; it avoids the risks of further limbal stem cell destruction from other agents and surgical excision. If invasive disease is diagnosed at any stage, topical therapy is contraindicated, necessitating surgical excision.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
David J. BSc, Graham A. MD, FRANZCO,